90 related articles for article (PubMed ID: 16506220)
41. Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis.
Franklin WA; Gazdar AF; Haney J; Wistuba II; La Rosa FG; Kennedy T; Ritchey DM; Miller YE
J Clin Invest; 1997 Oct; 100(8):2133-7. PubMed ID: 9329980
[TBL] [Abstract][Full Text] [Related]
42. Influence of cigarette smoking and schistosomiasis on p53 gene mutation in urothelial cancer.
Habuchi T; Takahashi R; Yamada H; Ogawa O; Kakehi Y; Ogura K; Hamazaki S; Toguchida J; Ishizaki K; Fujita J
Cancer Res; 1993 Aug; 53(16):3795-9. PubMed ID: 8339293
[TBL] [Abstract][Full Text] [Related]
43. 5' cytosine-phospho-guanine island methylation is responsible for p14ARF inactivation and inversely correlates with p53 overexpression in resected non-small cell lung cancer.
Hsu HS; Wang YC; Tseng RC; Chang JW; Chen JT; Shih CM; Chen CY; Wang YC
Clin Cancer Res; 2004 Jul; 10(14):4734-41. PubMed ID: 15269146
[TBL] [Abstract][Full Text] [Related]
44. p53 mutational spectrum of esophageal carcinomas from five different geographical locales in China.
Lung ML; Chan WC; Zong YS; Tang CM; Fok CL; Wong KT; Chan LK; Lau KW
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):277-84. PubMed ID: 8722219
[TBL] [Abstract][Full Text] [Related]
45. P53 in squamous metaplasia: a marker for risk of respiratory tract carcinoma.
Boers JE; ten Velde GP; Thunnissen FB
Am J Respir Crit Care Med; 1996 Jan; 153(1):411-6. PubMed ID: 8542151
[TBL] [Abstract][Full Text] [Related]
46. Immunohistochemical and oncogenetic analyses of the esophageal basaloid squamous cell carcinoma in comparison with conventional squamous cell carcinomas.
Imamhasan A; Mitomi H; Saito T; Hayashi T; Takahashi M; Kajiyama Y; Yao T
Hum Pathol; 2012 Nov; 43(11):2012-23. PubMed ID: 22607702
[TBL] [Abstract][Full Text] [Related]
47. On the origin of p53 G:C --> T:A transversions in lung cancers.
Rodin SN; Rodin AS
Mutat Res; 2002 Oct; 508(1-2):1-19. PubMed ID: 12379456
[TBL] [Abstract][Full Text] [Related]
48. Detection and sequencing of p53 gene mutations in bronchial biopsy samples in patients with lung cancer.
Mitsudomi T; Lam S; Shirakusa T; Gazdar AF
Chest; 1993 Aug; 104(2):362-5. PubMed ID: 8393397
[TBL] [Abstract][Full Text] [Related]
49. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
[TBL] [Abstract][Full Text] [Related]
50. Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms.
Popanda O; Edler L; Waas P; Schattenberg T; Butkiewicz D; Muley T; Dienemann H; Risch A; Bartsch H; Schmezer P
Lung Cancer; 2007 Jan; 55(1):25-34. PubMed ID: 17059853
[TBL] [Abstract][Full Text] [Related]
51. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas.
Hashimoto T; Tokuchi Y; Hayashi M; Kobayashi Y; Nishida K; Hayashi S; Ishikawa Y; Tsuchiya S; Nakagawa K; Hayashi J; Tsuchiya E
Cancer Res; 1999 Nov; 59(21):5572-7. PubMed ID: 10554037
[TBL] [Abstract][Full Text] [Related]
52. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients.
Liu D; Huang CL; Kameyama K; Hayashi E; Yamauchi A; Sumitomo S; Yokomise H
Cancer; 2002 Apr; 94(8):2239-47. PubMed ID: 12001123
[TBL] [Abstract][Full Text] [Related]
53. Frequent expression of p53 protein without mutation in the atypical epithelium of human bronchus.
Wakamatsu K; Nakanishi Y; Takayama K; Miyazaki H; Hayashi K; Hara N
Am J Respir Cell Mol Biol; 1999 Aug; 21(2):209-15. PubMed ID: 10423403
[TBL] [Abstract][Full Text] [Related]
54. Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development.
Rusch V; Klimstra D; Linkov I; Dmitrovsky E
Cancer Res; 1995 Mar; 55(6):1365-72. PubMed ID: 7882337
[TBL] [Abstract][Full Text] [Related]
55. Patterns of p53 G-->T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke.
Hainaut P; Pfeifer GP
Carcinogenesis; 2001 Mar; 22(3):367-74. PubMed ID: 11238174
[TBL] [Abstract][Full Text] [Related]
56. p53 Gene mutation and genetic instability in superficial multifocal esophageal squamous cell carcinoma.
Fujiki T; Haraoka S; Yoshioka S; Ohshima K; Iwashita A; Kikuchi M
Int J Oncol; 2002 Apr; 20(4):669-79. PubMed ID: 11894109
[TBL] [Abstract][Full Text] [Related]
57. Concurrent p53 expression in bronchial dysplasias and squamous cell lung carcinomas.
Nuorva K; Soini Y; Kamel D; Autio-Harmainen H; Risteli L; Risteli J; Vähäkangas K; Pääkkö P
Am J Pathol; 1993 Mar; 142(3):725-32. PubMed ID: 8456936
[TBL] [Abstract][Full Text] [Related]
58. Tobacco smoking and somatic mutations in human bronchial epithelium.
Yoshida K; Gowers KHC; Lee-Six H; Chandrasekharan DP; Coorens T; Maughan EF; Beal K; Menzies A; Millar FR; Anderson E; Clarke SE; Pennycuick A; Thakrar RM; Butler CR; Kakiuchi N; Hirano T; Hynds RE; Stratton MR; Martincorena I; Janes SM; Campbell PJ
Nature; 2020 Feb; 578(7794):266-272. PubMed ID: 31996850
[TBL] [Abstract][Full Text] [Related]
59. Nuclear accumulation of p53 is a potential marker for the development of squamous cell lung cancer in smokers.
Piyathilake CJ; Frost AR; Manne U; Weiss H; Heimburger DC; Grizzle WE
Chest; 2003 Jan; 123(1):181-6. PubMed ID: 12527620
[TBL] [Abstract][Full Text] [Related]
60. p53 mutational spectra and the role of methylated CpG sequences.
Pfeifer GP
Mutat Res; 2000 May; 450(1-2):155-66. PubMed ID: 10838140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
